Chamorey, E., Francois, E., Etienne, M., Ferrero, J., Peyrade, F., Barranger, E., . . . Milano, G. (2020). DPD status and fluoropyrimidines-based treatment: High activity matters too. BMC Cancer, 20(1), 1. https://doi.org/10.1186/s12885-020-06907-0
Chicago Style (17th ed.) CitationChamorey, Emmanuel, et al. "DPD Status and Fluoropyrimidines-based Treatment: High Activity Matters Too." BMC Cancer 20, no. 1 (2020): 1. https://doi.org/10.1186/s12885-020-06907-0.
MLA (9th ed.) CitationChamorey, Emmanuel, et al. "DPD Status and Fluoropyrimidines-based Treatment: High Activity Matters Too." BMC Cancer, vol. 20, no. 1, 2020, p. 1, https://doi.org/10.1186/s12885-020-06907-0.
Warning: These citations may not always be 100% accurate.